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ABSTRACT  
BACKGROUND: While health state utility values (HSUVs) for many single health 
conditions are now in the public domain, due to the large number of possible combinations of 
comorbid health conditions (CHC) the HSUVs for these are not readily available.  As a 
consequence, HSUVs for CHCs are frequently estimated using data obtained from cohorts 
with single health conditions.  With researchers presenting conflicting results, there is 
currently no consensus on the most appropriate method to estimate HSUVs for CHCs. 
 
OBJECTIVE: The objective of the study was to assess the accuracy of five different methods 
in the same dataset.   
 
METHODS: EQ-5D data (n=41,174) from the Health Survey for England was used to 
compare HSUVs generated using the following techniques: the additive, multiplicative and 
minimum methods, the adjusted decrement estimator (ADE), and a linear regression model.  
 
RESULTS: The additive and multiplicative methods under estimated the majority of HSUVs 
and the magnitude of the errors increased as the actual HSUV increased.  Conversely, the 
minimum and DAE methods over estimated the majority of HSUVs and the magnitude of 
errors increased as the actual HSUV decreased. Although the simple linear model produced 
more accurate results than the others, there was a tendency to under predict higher HSUVs 
and over predict lower HSUVs and 20% of the errors were greater than the MID (|0.074|) for 
the EQ-5D.  We found the magnitude and direction of mean errors in the estimated scores 
could be driven by the actual scores being estimated in addition to the technique used and in 
general the HSUVs estimated using an adjusted baseline were more accurate. 
 
We found the additive and minimum methods performed very poorly in our data.  While the 
simple linear model gave the most accurate results, the model requires validating in external 
data and additional research exploring alternative model specification is warranted.  Our 
comparison of errors in subgroups of actual EQ-5D scores highlights the need to present 
additional data when reporting results of analyses in this area as conclusions using average 
errors in truncated ranges could be misleading. 
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BACKGROUND 
Throughout the world economic evaluations in health care are used by policy decision makers 
to make informed decisions on whether new treatments should be reimbursed.  Clinical 
effects are measured in terms of health related quality of life (HRQoL) impacts and costs 
include the resources used and the intervention costs.  Treatments are appraised using a 
decision rule based on an incremental cost effectiveness ratio which utilises a generic HRQoL 
measure to quantify the cost per quality adjusted life year (QALY).[1]  The QALY is a metric 
that combines the duration of time spent in a health state with the HRQoL associated with the 
health state i.e. the health state utility value (HSUV).[2]  The rationale for the use of the 
QALY is to facilitate consistent reimbursement recommendations across all disease areas and 
systems thus allowing the optimal allocation of resources.  However, the use of inconsistent 
methods can undermine the aim for consistent decision making. 
 
Decision analytic models used to generate the cost effectiveness ratios are mathematical 
models which represent the health condition or system under appraisal.  Due to the ageing 
population and the increasing prevalence of concurrent health conditions, these models 
frequently describe comorbid health conditions (CHCs) such as arthritis and stroke.[3]  While 
there are a number of catalogues which provide HSUVs for cohorts with a single health 
condition, due to the enormous number of possible combinations of CHCs, the HSUVs for 
these are not readily available.  As a consequence, analysts estimate HSUVs for CHCs using 
data obtained from cohorts with single health conditions.  For example, the HSUV for a 
cohort with the CHC arthritis plus stroke would be estimated using the mean HSUV obtained 
from a cohort who have a history of arthritis (but not stroke) and the mean HSUV obtained 
from a cohort who have a history of stroke (but not arthritis).  HSUVs are estimated on a 
cohort level as opposed to an individual patient level as by definition individuals cannot have 
just a single health condition and a CHC. 
 
The three most commonly cited techniques used to estimate HSUVs for CHCs are the 
additive, multiplicative and minimum methods.  The additive and multiplicative methods 
assume constant absolute and proportional decrements respectively while the decrement 
associated with the minimum method can vary depending on the baseline used.  Two 
alternative techniques have recently been suggested.  First, the adjusted decrement estimator 
(ADE), a non parametric estimator based on the minimum method has been proposed.[4]  
Second, a hybrid model which incorporates terms representing the three traditional methods 
has been explored using ordinary least square regressions.[5] 
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The existing evidence base in this area is relatively small and there is currently no consensus 
on the most appropriate method.  Comparison of findings reported in the literature is hindered 
due to differences in study designs such as the preference based measure estimated, 
differences in datasets, methodologies compared, ranges of HSUVs estimated, and the 
statistics used to compare the estimated values.[6-8]  The methods can produce very different 
results and when applied in economic models the method used could potentially influence a 
policy decision based on a cost per QALY threshold.[9] 
 
The primary objective of the current study is to add to the existing evidence base through 
comparing all five methods in a single dataset.  We use EQ-5D data from the Health Survey 
for England to examine the results generated using the different techniques.  The next section 
provides a description of the alternative methods followed by the results of our analyses. 
 
METHODS 
Methods used to estimate HSUVS: Given two health conditions, condition A and condition B, 
there are four combinations possible: individuals have condition A but not condition B, 
individuals have condition B but not condition A, individuals have condition A and condition 
B; individuals do not have either condition A or condition B.  The HSUVs associated with 
these alternatives are defined as: UA, UB, UA,B, and UnA,nB. 
 
The additive method assumes a constant absolute decrement relative to the baseline and the 
HSUV for the CHC is estimated using: 
    BnbAnAnBnA
add
BA UUUUUU  ,,     (Eqn 1) 
If a baseline of perfect health is used, the additive method can be estimated using: 
1,  BA
add
BA UUU        (Eqn 2) 
 
The multiplicative method assumes a constant proportional decrement relative to the baseline 
and the HSUV for the CHC is estimated using: 
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If a baseline of perfect health is used, the multiplicative method can be estimated using: 
BA
mult
BA UUU ,        (Eqn 4) 
 
The minimum method assumes the HSUV for the CHC is equivalent to the minimum HSUV 
for the single health conditions within the CHC.  The HSUV for the CHC is estimated using: 
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 BAnBnABA UUUU ,,min ,min,        (Eqn 5) 
If a baseline of perfect health is used, the minimum method is estimated using: 
  BABA UUU ,min
min
,         (Eqn 6) 
 
The adjusted decrement estimator (ADE) has recently been proposed as an alternative 
method.[4]  The ADE assumes the estimated HSUV for the CHC has an upper bound equal to 
the minimum of the HSUVs from the two single health conditions.  Assuming a baseline of 
perfect health, the HSUV for the CHC is estimated using: 
       BABABA
ADE
BA UUUUUUU  11,min,min,   (Eqn 7) 
Using an adjusted baseline equation 7 can be written as follows: 
       BnbAnABABA
ADE
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A simple linear model which incorporates terms that represent the additive, multiplicative and 
minimum methods has recently been proposed.[5]  The model, which is based on decision 
theory, multi-attribute utility functions, and a prospect theory, [10-12] is defined by: 
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The beta coefficients are obtained using ordinary least square regressions and   represents 
the residual. 
 
Eqn 9 reduces to the additive method when 0 = 0, 1 = 1, 2 = 1 and 3 = 0 
Eqn 9 reduces to the multiplicative method when 0 = 0, 1 = 1, 2 = 1 and 3 = -1 
Eqn 9 reduces to the minimum method when 0 = 0, 1 = 1, 2 = 0 and 3 = 0 
 
If an adjusted baseline is used as opposed to a baseline of perfect health, he model could be 
defined by: 
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There is currently no consistency in the baseline used when estimating HSUVs for CHC and 
researchers have used a baseline of perfect health,[4,8] “purified” data by dividing all HSUVs 
by the mean HSUV obtained from individuals with none of the health conditions in a 
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particular dataset,[5,8] or estimated condition specific baselines.[6]  Using a baseline of 
perfect health overestimates the disutility associated with health conditions,[13] and results 
generated from analyses using a baseline of perfect health are not comparable to those 
generated using an adjusted baseline.[9]  It has been suggested that alleviating a health 
condition would at best increase the average HSUV to that observed in cohorts without the 
health condition.[14]  Consequently when estimating HSUVs, a baseline of perfect health 
may not be the most appropriate technique.  The ideal baseline would be the HSUV 
associated with not having a particular health condition.  I.e. the baselines for condition A, 
condition B, or both condition A and condition B, would be obtained from individuals who do 
not have the respective conditions.  Due to the enormous number of possible health conditions 
the data required to estimate condition specific baselines are not in the public domain.  We 
used age adjusted baseline HSUVs obtained from respondents who indicate they do not have 
any of the health conditions identified in the dataset used.  For comparison with results in the 
literature, we also generated results using a baseline of perfect health. 
 
Data 
The Health Survey for England (HSE) is an annual survey conducted on randomly selected 
samples of the population living in private households in England.[15-18]  The present study 
pools data from the 2003, 2004, 2005 and 2006 core HSE using the weight variables for the 
individual level self-administered questionnaire which adjusts for non response.  We used the 
chronic clinical conditions reported in the HSE which included 39 individual health 
conditions and 15 grouped health conditions. 
 
The EQ-5D is a widely used generic instrument that contains of five attributes of health status 
including: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.  Each 
of the attributes is measured by a question with three possible responses: no problem, some 
problem, or severe problem.  The combination of possible responses lead to a total of 243 
(3^5) possible health states.  A sample of these health states were weighted by the UK general 
public using time trade-off techniques and the resulting algorithm is used to calculate the 
preference-based HSUVs used in the current study.[19]  The preference-based index has a 
range of -0.59 to 1, whereby 1 represents perfect health, 0 represents death and negative 
values represent health states considered to be worse than death. 
 
Statistical Analyses 
The HSE data were subgrouped (n≥100) by health conditions using a) groups with comorbid 
pairs of health conditions (condition A and condition B) regardless of other health conditions, 
and b) groups with just one of the individual health conditions within each comorbid pair (i.e. 
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condition A but not condition B; condition B but not condition A).  The mean EQ-5D scores 
(referred to as “actual” EQ-5D scores from here on) and the mean age for each subgroup were 
calculated.  The mean EQ-5D scores from the subgroups with the single health conditions 
were then used to estimate mean EQ-5D scores (referred to as “estimated” EQ-5D scores 
from here on) for the corresponding CHC using the methods described previously. 
 
Performance of methods 
As we are interested in how well the methods estimate the actual EQ-5D scores, we assess the 
results in terms of the errors in the estimated HSUVs.  In addition to using the mean absolute 
errors (MAE), and root mean squared errors (RMSE), we examine the proportion of estimated 
values within the minimum important difference (MID) for the EQ-5D (MID = 0.074)[20] 
and the magnitude and direction of errors across the EQ-5D range. 
 
 
RESULTS 
The pooled data included 41,174 cases with EQ-5D scores.  The individual data covered the 
full index (-0.5940 to 1) and the mean HSUV for the cohort was 0.8679 (se 0.0014).  
Approximately 45% (18725/41174) of respondents reported having at least one chronic health 
condition.  The mean HSUV for this subgroup was 0.7565 (se 0.0026) compared with 0.9493 
(se 0.0009) for those who reported no chronic health condition.  The mean HSUVs for the 97 
subgroups (n ≥ 100) with two health conditions ranged from 0.3596 (se 0.0296) for 
respondents (n=171) who reported both mental illness/anxiety/depression and 
arthritis/rheumatism/fibrositis to 0.9165 (se 0.0140) for respondents (n=112) who reported 
both asthma and hay fever.  69% (67/97) of subgroups had a mean EQ-5D score below 0.6 
and none had a negative mean score (Figure 1).  As these are mean scores as opposed to 
HSUVs from individuals, the distribution is relatively normal. 
 
 
INSERT FIGURE 1: Distribution of mean EQ-5D scores for subgroups (n=97) with two 
comorbid health conditions 
 
 
Table 1 provides the results for the linear models obtained using ordinary least square 
regressions.  While the coefficients for the independent variables are all positive, which is as 
expected given the negative constant terms, none of the coefficients are significant (p>0.05).  
In both models the weight attributed to the maximum disutility are greater than the weight 
attributed to the minimum disutility and the interaction term has the largest coefficient. 
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INSERT TABLE 1 : Results from the OLS combination model 
 
 
Comparing the methods in terms of their accuracy (Table 2), the mean EQ-5D scores of the 
individual values predicted using the OLS combination models are the closest  to the actual 
mean values (0.5682) when using a baseline of perfect health (mean = 0.5669) and when 
using an age-adjusted baseline (mean = 0.5671).  However, the ranges of the predicted values 
are smaller than the actual range (actual range = 0.5570).  The minimum (ADE) methods 
produce the smallest range in estimated values at 0.2047 (0.2759) when using a baseline of 
perfect health, and 0.2715 (0.2415) when using an age-adjusted baseline respectively.  While 
the additive method produces the widest range in estimated values (0.4797 when using a 
baseline of perfect health and 0.4614 when using an age adjusted baseline), the increased 
range in estimated values is associated with the largest errors in the individual estimations 
(0.3320 when using a baseline of perfect health and 0.2792 when using an age adjusted 
baseline). 
 
The OLS models produce the smallest MAEs and RMSEs in the predicted values when using 
either a baseline of perfect health or when using an age-adjusted baseline (MAE: 0.047, 
RMSE: 0.060 for both analyses).  Conversely, the additive method produces the largest MAE 
and RMSE when using a baseline of perfect health (MAE: 0.1411, RMSE: 0.1529).  The 
errors for the additive method are reduced somewhat when using an age-adjusted baseline 
(MAE: 0.0872; RMSE: 0.1012).  While the mean errors give an indication of average 
accuracy across the full range of estimated values, these statistics do not reveal accuracy in 
individual estimated or predicted values and there are some substantial errors in the individual 
estimated HSUVs.  The additive method produces the largest individual error for both sets of 
analyses and the OLS model produces the smallest individual error for both sets. 
 
Of the non parametric methods, the additive and the minimum methods are the least accurate 
in terms of the proportion of individual values estimated to within a given magnitude of error 
irrespective of the baseline used.  Comparing the multiplicative and the ADE results, the 
baseline influences accuracy and when using an age adjusted baseline the multiplicative 
method produces the largest proportion (72% vs 52%) of individual values within the MID for 
the EQ-5D (|0.074| and the largest  proportion (56% vs 35%) accurate to within |0.05| of the 
actual HSUVs.  Conversely, when using a baseline of perfect health, the ADE method 
produces the largest proportion of values within these measures. 
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INSERT TABLE 2: Comparing the accuracy of HSUVs generated using the five methods 
 
 
When plotting the actual and estimated/predicted HSUVs (Figure 2) it can be seen that the 
values estimated using an age-adjusted baseline are more accurate than those estimated using 
a baseline of perfect health when using the additive and multiplicative methods.  However, 
the baseline is not as important for the other three methods.  For the additive method almost 
all values are underestimated across the full range of estimated values.  For the multiplicative 
method there is a tendency for the errors in the estimated values to decrease for lower HSUVs 
with the largest errors in values above 0.6.  Conversely, the errors in the minimum and ADE 
methods increase as the actual HSUV decreases with larger errors observed in estimates for 
lower HSUVs.  Although the errors in the HSUVS predicted using the OLS models are 
smaller than those in the other methods, there is a tendency to under predict higher HSUVs 
and over-predict lower HSUVs. 
 
 
INSERT FIGURE 2: Plot of actual and estimated EQ-5D scores 
 
The data were subgrouped into sets of equal numbers (Table 3) based on the actual EQ-5D 
score and the mean errors in each of the four groups were examined.  Presenting the data in 
this way reveals additional detail relating to the accuracy of the methods.  Using a baseline of 
perfect health, the additive and multiplicative methods produce smaller errors in HSUVs 
below 0.56 compared to errors in HSUVs above this.  Conversely, the minimum and ADE 
methods produce smaller errors in HSUVs above 0.562 compared to errors in HSUVs below 
this.  This trend holds regardless of the baseline used.  With the exception of the values 
predicted for the subgroup at the top of the range (EQ-5D greater than 0.624), the OLS model 
tends to be more accurate than all the non parametric methods although the multiplicative 
method is the most accurate for the subgroup at the lower end of the range (EQ-5D smaller 
than 0.514). 
 
 
 
DISCUSSION 
The purpose of this study was to assess the performance of the three techniques 
conventionally used to estimate mean HSUVs for comorbid conditions. I.e. the additive, 
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multiplicative and minimum methods, and the two more recently suggested alternatives, the 
ADE method and a simple linear regression model.  We found the additive and multiplicative 
methods under estimated the majority of HSUVs irrespective of the baseline used and the 
magnitude of the errors increases as the actual HSUV increases.  Conversely, the minimum 
and DAE methods over estimated the majority of HSUVs and the magnitude of errors 
increases as the actual HSUV decreases. Although the simple linear model produced more 
accurate results than the non parametric estimators, there was a tendency to under predict 
higher HSUVs and over predict lower HSUVs.  There were also some substantial errors in the 
individual predicted HSUVs with 20% of errors greater than the MID (|0.074|) for the EQ-5D. 
 
A methodological strength of this study is the relatively large range (0.360 to 0.917, 66% 
smaller than 0.60) in actual mean HSUVs for the combined health conditions.  Flanagan et al. 
assessed the multiplicative method using data from the Canadian Community Health Survey 
and reported 66% (185/278) of the mean HUI3 scores for cohorts with two health conditions 
was mild (greater than 0.80).[7]  Similarly, when comparing the multiplicative and additive 
methods using data from the Medical Expenditure Panel Survey (MEPS) the mean EQ-5D 
scores for cohorts with two comorbid health conditions were reported to be relatively mild 
(mean EQ-5D range 0.68 to 0.86).[6]  The range in actual HSUVs enabled us to assess 
performance of the methods across subgroups of the EQ-5D index and we found the 
magnitude and direction of mean errors in the estimated scores could be driven by the actual 
scores being estimated in addition to the technique used.  This suggests that conclusions based 
on truncated ranges using average errors could be misleading. 
 
Comparing the three original non parametric methods in terms of average errors and 
proportions of estimated HSUVs accurate to within a given magnitude, when using a baseline 
of perfect health, we found the additive method was the least accurate and the multiplicative 
method was the most accurate.  When using an age adjusted baseline, the accuracy for both 
the additive and multiplicative methods increased and the minimum method was the least 
accurate while the multiplicative method remained the most accurate.  These results do not 
support those reported by other researchers who found the minimum method gave the most 
accurate results when comparing the three methods in EQ-5D data obtained from the Medical 
Expenditure Panel Survey (MEPS).[8]  The difference in results are easily explained by 
comparing the ranges of actual HSUVs estimated.  The actual HSUVs for the comorbid health 
conditions in our data ranged from 0.360 to 0.917 with over two thirds of these below 0.60 
while the actual HSUVs in Fu’s data covered a much smaller range (approximately 0.62 to 
0.90).[4]  If we examine the average errors in a similar range (0.624 to 1), then the minimum 
method is more accurate than the additive and multiplicative methods in our data too. 
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Hu and Fu have recently proposed the ADE method based on analyses of the MEPS data used 
in the previous study.[4]  Using a baseline of perfect health they found the ADE was more 
accurate than the three traditional methods.  We also found the ADE method outperformed 
the other three non parametric methods in our data when using a baseline of perfect health, 
but when using an age adjusted baseline, the multiplicative method outperformed the ADE 
method.  Again, when examining the errors for the data subgrouped by actual EQ-5D score, 
the ADE method performed less favourably for lower HSUVs. 
 
One would intuitively expect that an additional health condition would have a negative effect 
on health related quality of life and that mean HSUVs for cohorts with comorbid health 
conditions would therefore be lower than the mean HSUV for cohorts with any of the single 
health conditions within the comorbid health condition.  However, some inconsistencies in 
HRQoL measurements are to be expected and in our dataset a small proportion (6/97) of the 
mean HSUVs for cohorts with a comorbid health condition were greater than one of the mean 
HSUVs for the corresponding single health conditions.  It is clear from charts presented in Hu 
and Fu’s article that this anomaly is observed in a substantial proportion of their data as 
approximately 25% of HSUVs estimated using the minimum method are smaller than the 
actual HSUV.[4]  This is possibly due to the fact that the health conditions in their data have a 
relatively small affect on HRQoL data and this may contribute to the difference in findings in 
their dataset. 
 
Although the simple linear model produced more accurate results than the non parametric 
estimators in our data, none of the coefficients in the model were significant and the model 
requires validating in external data.  The trend to under estimate higher HSUVs and over 
estimate lower HSUVs suggests that a different model specification may be warranted and 
additional research exploring alternatives would be beneficial.  A limitation of using 
regressions to explore relationships between HSUVs is that models are unlikely to be valid for 
HSUVs obtained using different preference-based measures thus each measure would require 
an individualised model. 
 
One additional problem of estimating HSUVs using the non parametric methods is associated 
with negative HSUVs.  The multiplicative method will produce a positive value when 
combining two negative values and the additive method could produce estimates below the 
minimum value on the preference-based index.  However, while analysts need to be aware of 
the potential  problem, when estimating mean scores for cohorts, the issues associated with 
negative scores will arise infrequently. 
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CONCLUSION 
This study makes an important contribution to the evidence in this area as it is the first to 
compare the five different techniques within the same study.  We found the additive and 
minimum methods performed very poorly in our data.  While the simple linear model gave 
the most accurate results, the model requires validating in external data and additional 
research exploring alternative model specification is warranted.  Our comparison of errors in 
subgroups of EQ-5D scores highlights the need to present additional data when reporting 
results of analyses in this area as average errors may not give an accurate picture of overall 
accuracy. 
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Table 1 : Results from the OLS combination models 
 Coefficient Robust  P value Coefficient Robust  P value 
  Std. Err.   Std. Err.  
Baseline: Perfect Health  None of Health Conditions 
Minimum 
decrement 
0.5136428 1.13 0.651 0.0439155 0.4978 0.93 
Maximum 
decrement 
0.5284501 1.3815 0.703 0.1545328 0.7076 0.828 
CrossProduct 1.789911 1.7784 0.317 1.143514 0.8307 0.172 
Constant   -0.6427511 1.6315 0.695 -0.1007821 0.7165 0.888 
R Sq 0.5747   0.5803   
       
Minimum decrement: min(UnA – UA, UnB – UB)   
Maximum decrement: max(UnA – UA, UnB – UB))   
CrossProduct: min(UnA, UnB))*(UA/UnA)*(UB/UnB)  
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Table 2: Comparing the accuracy of HSUVs generated using the five methods  
 ACTUAL Additive Multiplicative Minimum ADE OLS  
Using a baseline of perfect health 
Mean EQ-5D score 0.5682 0.4288 0.5092 0.6667 0.6142 0.5669 
Min EQ-5D score 0.3596 0.2321 0.3795 0.5860 0.5018 0.4367 
Max EQ-5D 0.9165 0.7119 0.7284 0.7907 0.7777 0.8121 
Range 0.5570 0.4797 0.3489 0.2047 0.2759 0.3754 
Mean error 0.1384 0.0580 -0.0995 -0.0470 0.0003 
Maximum error 0.3320 0.2129 0.2715 0.2206 0.1720 
       
MAE 0.1411 0.0707 0.1037 0.0620 0.0471 
RMSE 0.1529 0.0839 0.1214 0.0799 0.0603 
       
Proportion within |0.01| 0% 7% 4% 15% 11% 
Proportion within |0.05| 7% 39% 20% 46% 64% 
Proportion within MID |0.074| 15% 58% 33% 72% 81% 
Using age-adjusted baseline from individuals with none of health conditions 
Mean EQ-5D score 0.5682 0.4890 0.5418 0.6667 0.6367 0.5671 
Min EQ-5D score 0.3596 0.2918 0.4040 0.5860 0.5266 0.4266 
Max EQ-5D 0.9165 0.7532 0.7598 0.7907 0.7860 0.7955 
Range 0.5570 0.4614 0.3558 0.2047 0.2595 0.3689 
Mean error 0.0781 0.0254 -0.0995 -0.0695 0.0001 
Maximum error 0.2792 0.1800 0.2715 0.2415 0.1732 
      
MAE 0.0872 0.0516 0.1037 0.0781 0.0466 
RMSE 0.1012 0.0651 0.1214 0.0950 0.0598 
       
Proportion within |0.01| 7% 12% 4% 5% 13% 
Proportion within |0.05| 26% 56% 20% 35% 63% 
Proportion within MID |0.074| 40% 72% 33% 52% 80% 
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Table 3: Errors in estimated HSUVs sub-grouped by actual EQ-5D score 
EQ-5D subgroup Additive Multiplicative Minimum ADE OLS  
ME: Using a baseline of perfect health 
Full set (n=97) 0.1384 0.0580 -0.0995 -0.0470 0.0003 
1 to < 0.624 (n=23) 0.1730 0.1153 -0.0411 0.0007 0.0515 
0.624 to < 0.562 (n=24) 0.1481 0.0739 -0.0723 -0.0236 0.0176 
0.562 to < 0.514 (n=24) 0.1213 0.0403 -0.1069 -0.0550 -0.0151 
0.514 to < 0.35 (n=26) 0.1145 0.0090 -0.1694 -0.1035 -0.0469 
ME: Using age-adjusted baseline from individuals with none of health conditions 
Full set (n=97) 0.0781 0.0254 -0.0995 -0.0695 0.0001 
1 to < 0.624 (n=23) 0.1119 0.0779 -0.0411 -0.0201 0.0530 
0.624 to < 0.562 (n=24) 0.0871 0.0403 -0.0723 -0.0459 0.0141 
0.562 to < 0.514 (n=24) 0.0609 0.0082 -0.1069 -0.0776 -0.0174 
0.514 to < 0.35 (n=26) 0.0559 -0.0191 -0.1694 -0.1275 -0.0436 
MAE: Using a baseline of perfect health 
Full set (n=97) 0.1411 0.0707 0.1037 0.0620 0.0471 
1 to < 0.624 (n=23) 0.1730 0.1153 0.0579 0.0398 0.0596 
0.624 to < 0.562 (n=24) 0.1481 0.0739 0.0730 0.0454 0.0341 
0.562 to < 0.514 (n=24) 0.1234 0.0490 0.1069 0.0550 0.0375 
0.514 to < 0.35 (n=26) 0.1226 0.0482 0.1694 0.1035 0.0570 
MAE: Using age-adjusted baseline from individuals with none of health conditions 
Full set (n=97) 0.0872 0.0516 0.1037 0.0781 0.0466 
1 to < 0.624 (n=23) 0.1123 0.0803 0.0579 0.0472 0.0604 
0.624 to < 0.562 (n=24) 0.0871 0.0423 0.0730 0.0545 0.0320 
0.562 to < 0.514 (n=24) 0.0739 0.0397 0.1069 0.0776 0.0392 
0.514 to < 0.35 (n=26) 0.0775 0.0457 0.1694 0.1275 0.0548 
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Figure 1: Distribution of mean EQ-5D scores for subgroups with two comorbid health 
conditions 
4%
2%
15%
26%
22%
12% 12%
2%
1%
3%
0%
5%
10%
15%
20%
25%
30%
0.4 0.45 0.5 0.55 0.6 0.65 0.7 0.75 0.8 0.85 0.9 0.95
Mean EQ-5D score
P
ro
p
o
rt
io
n
 o
f 
ca
se
s
 
 
  
19 
Figure 2a: Actual and estimated mean EQ-5D scores using the additive method 
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Figure 2b: Actual and estimated mean EQ-5D scores using the multiplicative method 
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Figure 2c: Actual and estimated mean EQ-5D scores using the minimum method 
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Figure 2d: Actual and estimated mean EQ-5D scores using the ADE method 
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Figure 2e: Actual and predicted mean EQ-5D scores using the OLS regression model 
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